UT Health San Antonio scientists launch innovative therapy study to help Parkinson’s patients swallow safely

Three-year, $1.9 million DOD grant takes aim at dysphagia Swallowing difficulties, or dysphagia, affect up to 80% of people with Parkinson's disease and can lead to serious complications, including malnutrition, aspiration and reduced quality of life. With a new three-year, $1.9 million grant from the Department of Defense, Giselle Carnaby, PhD, MPH, a researcher at […]

August Global Partners Closes Flagship Healthcare Fund Above Target, Expanding AUM to $350 Million

August Global Partners (“AGP”), Asia's leading independent healthcare and technology investor, today announced the successful close of its second fund, the AGP Healthcare Fund (“AGPHC”) of $150 million, surpassing initial fundraising targets despite persistent headwinds in the global private equity and venture capital landscape. AGP's founding partners – who played a formative role in shaping

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy

(HKSE:6855),(NasdaqGM:AAPG), Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature's Signal Transduction and Targeted Therapy GlobeNewswire November 25, 2025 Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International

Merchant McIntyre Fly-In Amplifies the Voice of Rural Health Providers in Washington

Rural health system CEOs took center stage at Merchant McIntyre's (MM) second annual National Rural Health Day Fly-In on November 18th and 19th. Merchant McIntyre, a leading federal funding and advocacy firm serving nonprofits and public entities nationwide, brought eight rural health system CEOs to Washington for a series of high-level meetings with members of

Topgolf Callaway Brands to Participate in Jefferies Virtual Fireside Chat

Topgolf Callaway Brands Corp. (the “Company” or “Topgolf Callaway Brands”) (NYSE: MODG) today announced that President and Chief Executive Officer Chip Brewer will participate in a virtual fireside chat hosted by Jefferies analyst Randy Konik on November 25 at 9:00 a.m. PT. An accompanying deck will be posted to our investor relations website under webcasts

Investors SueWallSt Over WPP plc Stock Drop – Contact Levi & Korsinsky to Join

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / – SueWallSt: Class Action Filed Against WPP plc – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between February 27, 2025 and July 8, 2025. If you suffered

Public Notice – Have your say on the draft co-operation agreement between Manitoba and Canada

Public comments invited What is happening?In May 2025, the Government of Canada committed to striking co-operation agreements with every interested province within six months. These agreements will help achieve the Government's goal of “one project, one review” while upholding Canada's world-leading environmental standards and constitutional obligations to Indigenous Peoples. The Impact Assessment Agency of Canada

ROSEN, LEADING INVESTOR COUNSEL, Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL

New York, New York–(Newsfile Corp. – November 24, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public. SO WHAT:

Scroll to Top